Form 4 for SNDX Syndax Pharmaceuticals Inc
Accepted 2022-08-26 00:00:00 ET · period of report 2022-07-29 · accession 0001562180-22-006334 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-08-26 | 2022-07-29 | SNDX | Ordentlich Peter | CSO | J - Other | $14.12 | +265 | 265 | New | +$3,742 |
| DM | 2022-08-26 | 2022-08-24 | SNDX | Ordentlich Peter | CSO | M - OptEx | $6.32 | +25.0K | 23.1K | New | +$158.1K |
| DM | 2022-08-26 | 2022-08-24 | SNDX | Ordentlich Peter | CSO | S - Sale+OE | $25.04 | -25.0K | 265 | -99% | -$626.0K |
| DM | 2022-08-26 | 2022-08-24 | SNDX | Ordentlich Peter | CSO | M - OptEx | $0.00 | -25.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-07-29 | J | A | 265 | $14.12 | 265 | D | — | — | |
| 2 | Common | Common Stock | 2022-08-24 | M | A | 2,154 | $6.35 | 2,419 | D | — | — | |
| 3 | Common | Common Stock | 2022-08-24 | S | D | 2,154 | $25.04 | 265 | D | — | — | (F3) The sale prices ranged from $25.00 to $25.18. |
| 4 | Common | Common Stock | 2022-08-24 | M | A | 22,846 | $6.32 | 23,111 | D | — | — | |
| 5 | Common | Common Stock | 2022-08-24 | S | D | 22,846 | $25.04 | 265 | D | — | — | (F3) The sale prices ranged from $25.00 to $25.18. |
| 6 | Derivative | Stock Options (Right to buy) | 2022-08-24 | M | D | 22,846 | $0.00 | 0 | D | $6.32 · — to 2024-09-15 | 22,846 Common Stock | (F4) This option is fully vested. |
| 7 | Derivative | Stock Options (Right to buy) | 2022-08-24 | M | D | 2,154 | $0.00 | 0 | D | $6.35 · — to 2024-12-18 | 2,154 Common Stock | (F4) This option is fully vested. |